Many leading players are concentrated in the Americas owing to the rising awareness about viscosupplementation products, well-established markets, high healthcare expenditures, and numerous opportunities for growth. These companies have expanded their market in other regions as well. Major players in the market are investing a huge amount of money in research and development activities to launch better and cost-effective products in the viscosupplementation market. They are also focusing on expanding their geographical boundaries by launching new products in emerging markets of developing countries.
Furthermore, companies such as Sanofi, Fidia Farmaceutici s.p.a., Bioventus, Anika Therapeutics Inc., Ferring B.V. are the top five players in the market. Apart from this, Allergan, Hoffmann-La Roche, Zimmer Biomet, Smith & Nephew Plc, and Regen Lab SA are some of the well-established players in the global viscosupplementation market.
Sanofi ranks first in the global viscosupplementation market. The company is one of the most trusted pharmaceutical brands in the world. Amongst the viscosupplementation products, the company deals in Synvisc (Hylan G-F 20), Synvisc-One (Hylan G-F 20). It has a strong distribution network and a research and development team to innovate new products in the market.
Fidia Farmaceutici s.p.a. is the second largest in the global viscosupplementation market. The company focuses on therapeutic areas such as joint healthcare, tissue repair, and dermatology and provides products and services related to medical devices, pharmaceutical products, and nutritional products. The company’s products are popular with the brand name Hyalgan and Hymovis. It has subsidiaries in Parsippany, New Jersey, Germany, Kazakhstan, Spain, Russian Federation, and the United Arab Emirates.
Bioventus is the third largest in the global viscosupplementation market. The company deals in the manufacturing and marketing of viscosupplementation products. It operates in the viscosupplementation market through its subsidiary Seikagaku corporation. The company has a strong product portfolio which focuses on addressing the needs of the customer.
Anika Therapeutics Inc. holds the fourth largest position in the global viscosupplementation market. It operates in business segments including orthobiologics, dermal, and surgical and has strong brand recognition in the market. It provides products including Orthovisc, Orthovisc mini, Monovisc, Cingal, Orthovisc-T, Hyalofast, and Hyalonect. The company holds significant market share in the US and European markets.
A large number of companies are working in the global viscosupplementation market. Through extensive research, it is found that market players have adopted strategies such as product launches and collaborations. On the basis of the market study, we found some key players operating in this market which are Sanofi, Allergan, Hoffmann-La Roche, Zimmer Biomet, Smith & Nephew Plc, Anika Therapeutics Inc., Fidia Farmaceutici s.p.a., Ferring B.V., Bioventus, Regen Lab SA, and others.
Sanofi is one of the leading players in the market with a strong customer base and international presence. The company has good research and development base and also a strong network of distributors. Sanofi is known for its strong brands and quality products. Furthermore, the company is launching new and innovative products in the viscosupplementation market.
Bargaining Power of Suppliers
The suppliers in the global viscosupplementation market are viscosupplementation product manufacturers. There are limited suppliers present in the global viscosupplementation market. Switching cost of these suppliers is medium to low, and also it varies from product to product. Moreover, suppliers are likely to enter into strategic partnerships with distributors and specialty hospitals to increase sales. Due to the high cost of viscosupplements a limited number of customers are available in the market, and very few suppliers are there to cater to the needs of the customers which leads to intense competition between the existing suppliers. However, the quality of product plays an important role in the healthcare industry as the viscosupplementation products are used to treat knee problems and expected to provide relief. However, low-quality products are likely to hamper the standard of the procedure conducted on patients, and it can cause serious damage to the patients. Hence, healthcare service providers are selective about suppliers. Due to this, the overall bargaining power of suppliers in the global viscosupplementation market is medium.
Bargaining Power of Buyers
The bargaining power of buyers is medium in the global viscosupplementation market. The market has a limited number of buyers and limited viscosupplementation product manufacturing companies to cater to the need of the buyers. However, the viscosupplementation products are highly specialized and play an important role in resolving knee related medical complications, and the buyers of the viscosupplementation market are moderately inclined towards quality products manufactured by trusted companies. As the products are manufactured for the specific medical procedure and there are very few substitutes available in the market. Also, most of the buyers are hospitals and medical institutions providers; they are price sensitive. Moreover, they can exert pressure on the manufacturers due to the low switching cost and intense rivalry in the market, which is responsible for the increased bargaining power of buyers.
Threat of New Entrants
The threat of new entrants is medium in the global viscosupplementation market. Any manufacturing company trying to enter the market is required to accept or abide by the mandatory regulatory standards. However, the budget required for research and development of a product is high as compare to other industries. Viscosupplementation products are highly specialized and manufactured to be used in specific medical procedure and majority of the customers are using products of well-established brands and they are likely to prefer established brands over new market player due to quality concerns and to maintain the quality of healthcare service, which does not comfort the new entrants to enter the market easily. However, increasing awareness about minimally invasive knee surgeries in developing countries and increasing adoption of new technology in healthcare is likely to provide a favorable environment for new entrants.
Threat of Substitutes
The threat of substitutes in the global viscosupplementation market is medium to high. Viscosupplementation products are used for performing minimally invasive knee surgeries and providing relief in knee related complications. There are limited options available in the viscosupplementation market to serve the need of the customers which eliminates the threat of substitute. However, the dosage or the number of injections used in the procedure varies from brand to brand. Also, the medium degree of switching cost decreases the threat of substitutes. The overall threat of substitutes in the global viscosupplementation market is medium to high.
Rivalry
The rivalry in the global viscosupplementation market is medium to high. The medium degree of product differentiation and a limited number of customers increases the intensity of rivalry in the market. The market is growing with a prominent growth rate and likely to provide opportunities for major players to expand their geographical boundaries which will initiate cutthroat competition between major players to capture maximum market share in the emerging markets. Major players are trying to develop less expensive products to make these products more affordable in emerging markets. Players are engaged in developing a process to lower their manufacturing and logistics cost to increase profitability and to overcome the competition. Moreover, they are also developing advanced products for differentiating their brand from their competitors.
